BlackRock Investment Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $147K | Buy |
420
+5
| +1% | +$1.75K | ﹤0.01% | 3221 |
|
|
2016
Q3 | $167K | Buy |
415
+3
| +0.7% | +$1.21K | ﹤0.01% | 3220 |
|
|
2016
Q2 | $245K | Buy |
412
+404
| +5,050% | +$240K | ﹤0.01% | 3241 |
|
|
2016
Q1 | $4K | Hold |
8
| – | – | ﹤0.01% | 3850 |
|
|
2015
Q4 | $5K | Hold |
8
| – | – | ﹤0.01% | 3858 |
|
|
2015
Q3 | $4K | Hold |
8
| – | – | ﹤0.01% | 3981 |
|
|
2015
Q2 | $5K | Buy |
8
+5
| +167% | +$3.13K | ﹤0.01% | 3948 |
|
|
2015
Q1 | $25K | Hold |
3
| – | – | ﹤0.01% | 3382 |
|
|
2014
Q4 | $26K | Hold |
3
| – | – | ﹤0.01% | 3404 |
|
|
2014
Q3 | $14K | Buy |
3
+1
| +50% | +$4.67K | ﹤0.01% | 3526 |
|
|
2014
Q2 | $16K | Sell |
2
-30
| -94% | -$240K | ﹤0.01% | 3465 |
|
|
2014
Q1 | $169K | Buy |
+32
| New | +$169K | ﹤0.01% | 3231 |
|